Viking Therapeutics (VKTX) Q1 2024 Earnings

24AprConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.28
-0.25
-0.22
-0.19

Details

Expected EPS
-0.27668
Actual EPS
-0.26
Surprise EPS
0.02
Surprise Percent
+6.03%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.26 per share for Q1 2024.

0 Comments

Share your thoughts